The European Commission may exempt researchers from a copyright law to enable data mining, according to Nature News.
Proponents believe the Million European Genomes Alliance will spur research, stimulate the life sciences economy, and ultimately improve clinical care.
Interviews with leading UK scientists revealed apprehension about losing access to European funding, limitations on freedom of movement, and an exodus of biotechs to the EU.
Uncertainty in funding following the Brexit vote has led some UK researchers to be left out of European consortiums, the Guardian reports.
Researchers in the UK react to the vote there to leave the European Union.
Called CanPathPro, the research consortium aims to combine omics data and systems biology tools into a single commercial platform for testing cancer hypotheses.
Most researchers in the UK oppose leaving the European Union, Technology Review reports.
The European Union calls for all publicly funded scientific papers to be immediately freely accessible to the public by 2020.
University of Copenhagen researchers will examine the possibility of using next-generation sequencing to reconstruct the genomes of ancient and extinct species.
The Netherlands is pushing the European Union to make a move on open access.
In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.
Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.
The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.
Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.